Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-06-29
DOI
10.1038/srep11702
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Facile Identification of Dual FLT3-Aurora A Inhibitors: A Computer-Guided Drug Design Approach
- (2014) Yung Chang Hsu et al. ChemMedChem
- Identification of ligand efficient, fragment-like hits from an HTS library: structure-based virtual screening and docking investigations of 2H- and 3H-pyrazolo tautomers for Aurora kinase A selectivity
- (2014) Sailu Sarvagalla et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance
- (2013) Michael R. Grunwald et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences
- (2013) Art D. Bochevarov et al. INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY
- Pharmacophore-based virtual screening and density functional theory approach to identifying novel butyrylcholinesterase inhibitors
- (2012) Sugunadevi Sakkiah et al. ACTA PHARMACOLOGICA SINICA
- 3-Phenyl-1H-5-pyrazolylamine-based derivatives as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)
- (2012) John T.-A. Hsu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Anti-influenza Drug Discovery: Identification of an Orally Bioavailable Quinoline Derivative through Activity- and Property-Guided Lead Optimization
- (2012) Jiann-Yih Yeh et al. ChemMedChem
- FLT3 inhibition: a moving and evolving target in acute myeloid leukaemia
- (2012) A Y H Leung et al. LEUKEMIA
- Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia
- (2012) Catherine C. Smith et al. NATURE
- The Development of Novel Therapies for the Treatment of Acute Myeloid Leukemia (AML)
- (2012) Sarit Assouline et al. Cancers
- Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)
- (2011) Wen-Hsing Lin et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Targeting the DFG-in kinase conformation: a new trend emerging from a patent analysis
- (2011) Mauro Angiolini Future Medicinal Chemistry
- Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode
- (2010) Marvin J. Meyers et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Activation State-Dependent Binding of Small Molecule Kinase Inhibitors: Structural Insights from Biochemistry
- (2010) Lisa M. Wodicka et al. CHEMISTRY & BIOLOGY
- Investigation of binding features: Effects on the interaction between CYP2A6 and inhibitors
- (2010) Chunzhi Ai et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Design and Synthesis of Tetrahydropyridothieno[2,3-d]pyrimidine Scaffold Based Epidermal Growth Factor Receptor (EGFR) Kinase Inhibitors: The Role of Side Chain Chirality and Michael Acceptor Group for Maximal Potency
- (2010) Chia-Hsien Wu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Anti-Influenza Drug Discovery: Structure−Activity Relationship and Mechanistic Insight into Novel Angelicin Derivatives
- (2010) Jiann-Yih Yeh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome
- (2009) S. Kayser et al. BLOOD
- AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)
- (2009) P. P. Zarrinkar et al. BLOOD
- Identification, SAR Studies, and X-ray Co-crystallographic Analysis of a Novel Furanopyrimidine Aurora Kinase A Inhibitor
- (2009) Mohane Selvaraj Coumar et al. ChemMedChem
- CHARMM: The biomolecular simulation program
- (2009) B. R. Brooks et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Generation of Ligand-Based Pharmacophore Model and Virtual Screening for Identification of Novel Tubulin Inhibitors with Potent Anticancer Activity
- (2009) Yi-Kun Chiang et al. JOURNAL OF MEDICINAL CHEMISTRY
- DOCK 6: Combining techniques to model RNA-small molecule complexes
- (2009) P. T. Lang et al. RNA
- Modelling the structures of G protein-coupled receptors aided by three-dimensional validation
- (2008) Siavoush Dastmalchi et al. BMC BIOINFORMATICS
- A theoretical antioxidant pharmacophore for resveratrol
- (2008) Auriekson N. Queiroz et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation
- (2008) Berk Hess et al. Journal of Chemical Theory and Computation
- Refining homology models by combining replica-exchange molecular dynamics and statistical potentials
- (2008) Jiang Zhu et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now